Patients News | pharmaphorum

News

Amazon unveils $5 subscription service for generics

Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients' homes in

News

blood_pressure_cuff_mockup_graphics_unsplash

Unmedicated nation: COVID cuts heart drug use in GB

Hundreds of thousands of people in Great Britain have missed out on receiving medication that could protect them from serious cardiovascular disease (CVD) as a result of the COVID-19 pandem

News

NICE backs Alnylam's Amvuttra for rare form of amyloidosis

Alnylam's gene-silencing drug Amvuttra has been recommended as a treatment for hereditary transthyretin-related (ATTR) amyloidosis by NICE, paving the way for the drug to be made available

News

Digital monitoring could be a leveller in diabetes therapy

A digital tool developed by DarioHealth has been shown to help patients with type 2 diabetes manage their blood sugar more effectively, regardless of their demographic background, in a new

News

NHS Confederation, ABPI report focuses on industry collabora...

According to a joint report published today from the

News

AstraZeneca backs AI-based lung cancer diagnosis pilot in UK

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists d

Amazon unveils $5 subscription service for generics

Unmedicated nation: COVID cuts heart drug use in GB

NICE backs Alnylam's Amvuttra for rare form of amyloidosis

Digital monitoring could be a leveller in diabetes therapy

NHS Confederation, ABPI report focuses on industry collabora...

AstraZeneca backs AI-based lung cancer diagnosis pilot in UK

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks